Tema Cardiovascular and Metabolic ETF (HRTS) Dividend Yield, History & Forecast

Tema Cardiovascular and Metabolic ETF (HRTS) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 1.29% ($0.47 per share annually (TTM)). The most recent ex-dividend date was December 10, 2025, with payment scheduled for December 11, 2025. market capitalization is approximately $53M.

HRTS fund composition

HRTS holds 45 positions, with 48.2% of assets in its ten largest. It charges an expense ratio of 0.99%, and manages $54.8M.

Top 10 holdings

HoldingWeight
LLYELI LILLY & CO11.10%
UNHUNITEDHEALTH GROUP INC5.54%
NOVO-B.CONOVO NORDISK A/S5.06%
TMOTHERMO FISHER SCIENTIFIC INC4.56%
RHHBYROCHE HOLDING AG4.23%
MRKMERCK & CO INC4.10%
JNJJOHNSON & JOHNSON3.85%
RVMDREVOLUTION MEDICINES INC3.36%
NOVN.SWNOVARTIS AG3.27%
CYTKCYTOKINETICS INC3.17%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about Tema Cardiovascular and Metabolic ETF (HRTS)

What is Tema Cardiovascular and Metabolic ETF's dividend yield?
Tema Cardiovascular and Metabolic ETF (HRTS) pays a current trailing twelve-month dividend yield of 1.29%, which works out to $0.47 per share annually based on the most recent payout schedule.
When does Tema Cardiovascular and Metabolic ETF pay distributions?
The most recent ex-dividend date was December 10, 2025. The next scheduled dividend payment date is December 11, 2025.
What does Tema Cardiovascular and Metabolic ETF invest in?
The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management.